|
Feb 24, 2026 |
Huston Thad Allen
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 18, 2026 |
Feb 19, 2026 |
Sorg Elaine K.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 19, 2026 |
Sorg Elaine K.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 15, 2026 |
Feb 18, 2026 |
Raymon Heather
|
SVP, Research and Development |
Sell |
90.0
|
+44,479
|
41.63%
|
✗
|
$6.1K |
| Feb 15, 2026 |
Feb 18, 2026 |
Horan Christopher
|
Chief Tech Operations Officer |
Sell |
90.0
|
+115,113
|
62.11%
|
✗
|
$8.7K |
| Feb 15, 2026 |
Feb 18, 2026 |
Bush Jennifer
|
COO |
Sell |
91.3
|
+113,785
|
48.85%
|
✗
|
$14.1K |
| Feb 15, 2026 |
Feb 18, 2026 |
Banerjee Subhashis
|
Chief Medical Officer |
Neutral |
90.0
|
+102,000
|
204.00%
|
✗
|
- |
| Feb 15, 2026 |
Feb 18, 2026 |
Aslan Fred
|
CEO |
Sell |
95.0
|
+352,250
|
29.11%
|
✗
|
$58.4K |
| Dec 15, 2025 |
Dec 15, 2025 |
Aslan Fred
|
CEO |
Sell |
52.5
|
-3,187
|
-0.26%
|
✓
|
$19.1K |
| Dec 12, 2025 |
Dec 12, 2025 |
Raymon Heather
|
SVP, Research and Development |
Neutral |
90.0
|
+67,253
|
169.87%
|
✗
|
- |
| Dec 12, 2025 |
Dec 12, 2025 |
Horan Christopher
|
Chief Tech Operations Officer |
Neutral |
90.0
|
+107,156
|
137.06%
|
✗
|
- |
| Dec 12, 2025 |
Dec 12, 2025 |
Bush Jennifer
|
COO |
Neutral |
90.0
|
+84,877
|
57.33%
|
✗
|
- |
| Dec 12, 2025 |
Dec 12, 2025 |
Aslan Fred
|
CEO |
Neutral |
90.0
|
+869,136
|
252.66%
|
✗
|
- |
| Nov 15, 2025 |
Nov 17, 2025 |
Raymon Heather
|
SVP, Research and Development |
Sell |
27.5
|
-1,375
|
-3.36%
|
✗
|
$4.5K |
| Nov 15, 2025 |
Nov 17, 2025 |
Horan Christopher
|
Chief Tech Operations Officer |
Sell |
27.5
|
-1,899
|
-2.37%
|
✗
|
$6.2K |
| Nov 15, 2025 |
Nov 17, 2025 |
Bush Jennifer
|
COO |
Sell |
27.5
|
-3,055
|
-2.02%
|
✗
|
$9.9K |
| Nov 15, 2025 |
Nov 17, 2025 |
Krishnamohan Neha
|
CFO |
Sell |
26.3
|
-3,490
|
-3.39%
|
✗
|
$11.3K |
| Nov 15, 2025 |
Nov 17, 2025 |
Aslan Fred
|
CEO |
Sell |
41.3
|
-12,722
|
-3.57%
|
✓
|
$42.1K |
| Oct 17, 2025 |
Oct 17, 2025 |
Aslan Fred
|
CEO |
Sell |
32.5
|
-25,500
|
-6.67%
|
✓
|
$153K |
| May 15, 2025 |
Aug 18, 2025 |
Aslan Fred
|
CEO |
Sell |
28.8
|
-34,444
|
-8.27%
|
✓
|
$91.4K |
| May 15, 2025 |
Aug 18, 2025 |
Raymon Heather
|
SVP, Research and Development |
Sell |
27.5
|
-2,384
|
-5.50%
|
✗
|
$6.1K |
| May 15, 2025 |
Aug 18, 2025 |
Krishnamohan Neha
|
CFO |
Sell |
26.3
|
-7,154
|
-6.50%
|
✗
|
$18.8K |
| May 15, 2025 |
Aug 18, 2025 |
Bush Jennifer
|
COO |
Sell |
26.3
|
-8,346
|
-5.23%
|
✗
|
$21.8K |
| May 15, 2025 |
Aug 18, 2025 |
Horan Christopher
|
Chief Tech Operations Officer |
Sell |
26.3
|
-4,918
|
-5.79%
|
✗
|
$12.7K |
| Jun 24, 2025 |
Jun 26, 2025 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 24, 2025 |
Jun 26, 2025 |
MOORE ALISON
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 24, 2025 |
Jun 26, 2025 |
Baker Daniel G.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 24, 2025 |
Jun 26, 2025 |
HOUGEN ELIZABETH L
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 24, 2025 |
Jun 26, 2025 |
Stoppel Laura
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 24, 2025 |
Jun 26, 2025 |
Miralles Gines Diego
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 24, 2025 |
Jun 26, 2025 |
DANIELS BRIAN
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 8, 2025 |
Apr 25, 2025 |
Banerjee Subhashis
|
Chief Medical Officer |
Neutral |
90.0
|
+50,000
|
100.00%
|
✗
|
- |
|
Apr 25, 2025 |
Banerjee Subhashis
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 5, 2025 |
Mar 7, 2025 |
Aslan Fred
|
CEO |
Neutral |
90.0
|
+200,000
|
92.31%
|
✗
|
- |
| Feb 26, 2025 |
Feb 28, 2025 |
Raymon Heather
|
SVP, Research and Development |
Neutral |
90.0
|
+33,350
|
333.50%
|
✗
|
- |
| Feb 26, 2025 |
Feb 28, 2025 |
Graef Thorsten
|
Chief Medical Officer |
Neutral |
90.0
|
+60,000
|
300.00%
|
✗
|
- |
| Feb 26, 2025 |
Feb 28, 2025 |
Horan Christopher
|
Chief Tech Operations Officer |
Neutral |
90.0
|
+60,000
|
240.00%
|
✗
|
- |
| Feb 26, 2025 |
Feb 28, 2025 |
Krishnamohan Neha
|
CFO |
Neutral |
90.0
|
+60,000
|
120.00%
|
✗
|
- |
| Feb 26, 2025 |
Feb 28, 2025 |
Bush Jennifer
|
COO |
Neutral |
90.0
|
+86,650
|
119.03%
|
✗
|
- |
| Jan 28, 2025 |
Jan 29, 2025 |
Baker Daniel G.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 29, 2025 |
Baker Daniel G.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 21, 2024 |
Oct 22, 2024 |
MOORE ALISON
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Oct 22, 2024 |
MOORE ALISON
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 12, 2024 |
Sep 13, 2024 |
Raymon Heather
|
SVP, Research and Development |
Neutral |
90.0
|
+10,000
|
100.00%
|
✗
|
- |
| Sep 12, 2024 |
Sep 13, 2024 |
Graef Thorsten
|
Chief Medical Officer |
Neutral |
90.0
|
+20,000
|
100.00%
|
✗
|
- |
| Sep 12, 2024 |
Sep 13, 2024 |
Horan Christopher
|
Chief Tech Operations Officer |
Neutral |
90.0
|
+25,000
|
100.00%
|
✗
|
- |
| Sep 12, 2024 |
Sep 13, 2024 |
Krishnamohan Neha
|
CFO |
Neutral |
90.0
|
+50,000
|
100.00%
|
✗
|
- |
| Sep 12, 2024 |
Sep 13, 2024 |
Bush Jennifer
|
COO |
Neutral |
90.0
|
+50,000
|
219.31%
|
✗
|
- |
| Jul 22, 2024 |
Jul 24, 2024 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Buy |
100.0
|
+8,795,020
|
459.88%
|
✗
|
$104.7M |
| Jul 22, 2024 |
Jul 24, 2024 |
5AM Partners VI, LLC
|
10% Owner |
Buy |
100.0
|
+1,295,020
|
122.37%
|
✗
|
$14.7M |
| Jul 22, 2024 |
Jul 22, 2024 |
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
|
10% Owner |
Buy |
97.5
|
+49,019
|
33.79%
|
✗
|
$500K |
| Jul 22, 2024 |
Jul 22, 2024 |
venBio Global Strategic Fund III, L.P.
|
10% Owner |
Buy |
100.0
|
+878,353
|
83.00%
|
✗
|
$5M |
| Jul 22, 2024 |
Jul 22, 2024 |
GC Corp.
|
10% Owner |
Buy |
100.0
|
+2,633,765
|
136.21%
|
✗
|
$30.6M |
| Jul 22, 2024 |
Jul 22, 2024 |
Huh Yong-Jun
|
Director |
Buy |
100.0
|
+2,633,765
|
136.21%
|
✗
|
$30.6M |
| Jul 22, 2024 |
Jul 22, 2024 |
Aslan Fred
|
CEO |
Neutral |
90.0
|
+228,905
|
100.00%
|
✗
|
- |
|
Jul 18, 2024 |
venBio Global Strategic Fund III, L.P.
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 18, 2024 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 18, 2024 |
5AM Partners VI, LLC
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 18, 2024 |
Miralles Gines Diego
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 18, 2024 |
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 18, 2024 |
Stoppel Laura
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 18, 2024 |
GC Corp.
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 18, 2024 |
HOUGEN ELIZABETH L
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 18, 2024 |
DANIELS BRIAN
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 18, 2024 |
Raymon Heather
|
SVP, Research and Development |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 18, 2024 |
Huh Yong-Jun
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 18, 2024 |
Bessen Laura
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 18, 2024 |
Graef Thorsten
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 18, 2024 |
Krishnamohan Neha
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 18, 2024 |
Horan Christopher
|
Chief Tech Operations Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 18, 2024 |
Bush Jennifer
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 18, 2024 |
Aslan Fred
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |